AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

3.2 min readPublished On: January 19th, 2022By

HAMBURG, Germany and PERTH, Australia – Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) a distributor of medical and CBD wellness cannabis products in Germany announces that its subsidiary, AMP Alternative Medical Products GmbH and Little Green Pharma Ltd. (ASX: LGP), a cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany, including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils.

AMP has entered into a three-year exclusive pharmaceutical distribution agreement for LGP Classic full-plant cannabis extract oils. LGP medical cannabis products have been registered for sale with the relevant authorities in Germany and include 20:5 LGP Classic and 10:10 LGP Classic extract oils in 30 and 50 milliliter sizes. Doctors and pharmacists can find more information about the product or order on AMP’s website: https://amp-eu.com/doccheck-login.

LGP is a pioneer and leader in producing medical cannabis extract oils with GMP cultivation facilities in Australia and Denmark, whose medical cannabis preparations provide various THC and CBD profiles available as LGP Classic medicinal cannabis oils. LGP medicinal cannabis oils are manufactured from a whole-plant (full spectrum) extract together with medium-chain triglyceride (MCT) oil. LGP was among the first medical cannabis companies to produce and export medical cannabis oils to Germany and continues to build its reputation in Europe by being selected as the primary medicinal cannabis extract oil supplier in France’s two-year medical cannabis trials being conducted by the French National Agency for the Safety of Medicines and Health Products (L’Agence nationale de sécurité du médicament et des produits de santé, or ANSM).

LGP medical cannabis extract oils shall also be used in Waldhausklinik Deuringen gGmbH (“Waldhausklinik”) clinical study into the therapeutic use of cannabis extracts focusing on pain therapy for patients suffering from multilocular chronic pain. Waldhausklinik is a non-profit acute care hospital for internal medicine in the Free State of Bavaria and has entered into a research collaboration with AMP into the efficacy and safety of medical cannabis.

Dr. Stefan Feuerstein, President and Director of Greenrise Global and Managing Director of AMP, commented, “We are seeing the industry mature with the growth of pharmaceutical cannabis products over flowers and are excited about adding LGP medical cannabis extracts to our portfolio.”

Ms. Fleta Solomon, Managing Director of Little Green Pharma, commented, “We set the strategic objective to be one of the leading medical cannabis extract producers and distributors in Europe, which means being a leader in Germany, the largest medical cannabis market in the world. Our partnership with Greenrise Global’s daughter company, AMP Alternative Medical Products GmbH, puts us on course to that path.”

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements that are based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and the timing thereof. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements do not guarantee future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.

(This information is primarily sourced from Greenrise Global Brands Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!